Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
My Lists

Allergan  (Stock symbol: AGN )

2525 Dupont Drive
Irvine, CA 92612
Website Company Summary Management Team

Management: F Ball (President);  June Bray (SVP Regulatory Affairs and Medical Writing) Raymond Diradoorian (Executive VP);  Samuel Gesten (Executive VP);  Douglas Ingram (Executive VP);  Matthew Maletta (VP);  Scott Whitcup (Executive VP) David E Pyott (Chairman of the Board);  Jeffrey Edwards (CFO)
Business Description

Allergan, a multi-specialty health care company focused on developing and commercializing pharmaceuticals, biologics and medical devices. It discovers, develops and commercializes pharmaceutical, medical device and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets.It has two reportable segments: specialty pharmaceuticals and medical devices. The specialty pharmaceuticals segment produces a range of products, including ophthalmic products for chronic dry eye, glaucoma therapy, ocular inflammation,allergy and retinal diseases. The medical devices segment produces a range of medical devices, including breast implants, the Lap-Band System and the Orbera Intragastric Balloon System and facial aesthetics products.As of February 26, 2010, the Company acquired Serica Technologies, Inc.
Customer on 9  Companies

Last Tweets


Last Mentions

Record updated: Sep 2010
Ownership: Public  
Stock Symbol: AGN